Cardiovascular disease (CVD) is the leading cause of death in women, who have a notable
increase in the risk for this disease after menopause and typically develop coronary heart …

Clinicians can encounter sex and gender disparities in diagnostic and therapeutic
responses. These disparities are noted in epidemiology, pathophysiology, clinical …

Objective To consolidate evidence from systematic reviews and meta-analyses investigating
the association between reproductive factors in women of reproductive age and their …

Background Some studies, mainly from high-income countries (HICs), report that women
receive less care (investigations and treatments) for cardiovascular disease than do men …

Background Hypertensive disorders of pregnancy (HDP) are associated with increased risks
for cardiovascular disease later in life. The HDP incidence is commonly assessed using …

Background The use of intensive lipid-lowering therapy by means of statin medications is
recommended after transient ischemic attack (TIA) and ischemic stroke of atherosclerotic …

Cardio-obstetrics has emerged as an important multidisciplinary field that requires a team
approach to the management of cardiovascular disease during pregnancy. Cardiac …

Hypertension (HTN) is a major modifiable risk factor for cardiovascular disease (CVD)
morbidity and mortality. The left ventricle (LV) is a primary target for HTN end-organ damage …

Antiplatelet agents and anticoagulants are a mainstay for the prevention and treatment of
thrombosis. However, despite advances in antithrombotic therapy, a fundamental challenge …

Preeclampsia is defined as new-onset hypertension after the 20th wk of gestation along with
evidence of maternal organ failure. Rates of preeclampsia have steadily increased over the …